Osteoporosis drugs increase bone necrosis risk

A popular class of osteoporosis drugs, bisphosphonates nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain, revealed by researchers in a study. The research conducted by reasearchers at the University of British Columbia and Vancouver Coastal Health Research Institute, Canada.
The report is published online by the Journal of Rheumatology, the findings follow a recent U.S. Food and Drug Administration alert about bisphosphonates that highlighted the possibility of severe and sometimes incapacitating bone, joint and/or muscle pain in patients taking the drugs.
The research is the largest study of bone necrosis and bisphosphonates, a class of drugs used by millions of women worldwide to help prevent bone fractures due to osteoporosis. It is the first study to explore the link between bone necrosis and specific brands of bisphosphonates, such as Actonel, Didrocal and Fosamax. Researchers found that all three brands had similar outcomes.
Bone necrosis, a relatively rare disease diagnosed in approximately 1 in 20,000 people per year, leads to permanent loss of blood supply to the bones. Without adequate blood supply, the bone tissue dies and causes the bone to collapse. The disease primarily affects shoulders, knees and hips at the joints, causing severe pain and immobility.
"The message for women taking these medications is to pay attention to your pain," said principal investigator Dr. Mahyar Etminan of the Centre for Clinical Epidemiology and Evaluation at UBC and VCHRI. "Given the widespread use of these drugs, it is important that women and their doctors know the risks that come with taking them."
(Published at Health News Track on January 17, 2008 - 355 days ago)
Osteoporosis article/news source:
University of British Columbia - read other
health news articles from University of British Columbia and
health news articles from Canada.
Osteoporosis - related articles/news stories:
-
Merck's Odanacatib increases bone mineral density-
Genetically modified carrots provide more calcium for osteoporosis patients-
Oral osteoporosis medicines safe during dental work-
Women with osteoporosis have increased long-term risk for new fracture-
Predicting hip fracture risk in postmenopausal women»»
Use OTC cough and cold products with care««
Enbrel, etanercept improved psoriasis in children and adolescents
MissionHealth Newstrack is dedicated to serve recent and updated health news & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Bookmark this pageHealth News Track is tracking world's medical health news daily.
Current news
FDA is highlighting the possibility of severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking bisphosphonates.
OsteoporosisThe word osteoporosis literally means "porous bones." It occurs when bones lose an excessive amount of their protein and mineral content, particularly calcium. Over time, bone mass, and therefore bone strength, is decreased. As a result, bones become fragile and break easily. Even a sneeze or a sudden movement may be enough to break a bone in someone with severe osteoporosis.
Osteoporosis articles